Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice

J Gastroenterol Hepatol. 2010 Feb;25(2):413-9. doi: 10.1111/j.1440-1746.2009.05969.x. Epub 2009 Sep 27.

Abstract

Background and aim: As ornithine carbamyltransferase (OCT) has proved to be a sensitive serum marker in the detection of hepatotoxicity in several models, it is important to confirm its application to the diagnosis of non-alcoholic fatty liver disease.

Methods: C57BL/6, KK-Ta and KK-Ay mice were fed a high-fat diet for 8 weeks and serum enzyme markers were examined. Serum OCT and alanine aminotransferase (ALT) were also measured in diabetic obese ob/ob and db/db mice fed a normal diet. Liver damage in these mice was evaluated by the hepatic content of tumor necrosis factor-alpha.

Results: Serum levels of OCT increased in KK-Ay fed a high-fat diet compared with the normal diet-fed group, whereas C57BL/6 and KK-Ta mice were not affected. In ob/ob mice, the relative increase was always greater in OCT than in ALT. In contrast, in db/db mice, the relative increase was always greater in ALT. Hepatic tumor necrosis factor-alpha was significantly elevated in ob/ob mice, but not in db/db mice.

Conclusions: Serum OCT seemed to reflect tumor necrosis factor-alpha-mediated hepatic damage when compared with ALT in diabetic obese mice and could be useful in the application for non-alcoholic fatty liver disease with features of metabolic syndrome, such as obesity and diabetes.

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Biomarkers / blood
  • Body Weight
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / enzymology
  • Diabetes Mellitus, Type 2 / pathology
  • Disease Models, Animal
  • Fatty Liver / enzymology
  • Fatty Liver / etiology*
  • Fatty Liver / pathology
  • Female
  • Lipid Metabolism
  • Liver / enzymology*
  • Liver / pathology
  • Mice
  • Mice, Inbred C57BL
  • Obesity / complications*
  • Obesity / enzymology
  • Obesity / pathology
  • Organ Size
  • Ornithine Carbamoyltransferase / blood*
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation

Substances

  • Biomarkers
  • Tumor Necrosis Factor-alpha
  • Ornithine Carbamoyltransferase
  • Alanine Transaminase